STOCK TITAN

Brunswick Corp (NYSE: BC) director receives 989-share stock grant and updates holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BRUNSWICK CORP director David V. Singer reported a compensation grant of common stock and updated holdings. He received 989 shares of common stock as a grant or award at $79.45 per share, bringing his direct holdings to 36,360 shares. He also reports 19,789 shares held indirectly through the Barbara B Singer 2014 Irrevocable Trust. Footnotes note that 415 of the reported shares are deferred shares to be distributed after he ceases being a director, and 168 shares were acquired through dividend reinvestment.

Positive

  • None.

Negative

  • None.
Insider SINGER DAVID V
Role null
Type Security Shares Price Value
Grant/Award Common Stock 989 $79.45 $79K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 36,360 shares (Direct, null); Common Stock — 19,789 shares (Indirect, Barbara B Singer 2014 Irrevocable Trust)
Footnotes (1)
  1. 415 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 168 shares acquired pursuant to dividend reinvestment through March 2026.
Stock grant size 989 shares Common stock grant or award to director on April 30, 2026
Grant value per share $79.45 per share Value used for the 989-share common stock grant
Direct holdings after grant 36,360 shares Common stock directly owned by David V. Singer following transaction
Indirect trust holdings 19,789 shares Common stock held by Barbara B Singer 2014 Irrevocable Trust
Deferred shares 415 shares Deferred shares in director’s deferred account for post-service distribution
Dividend reinvestment shares 168 shares Shares acquired through dividend reinvestment through March 2026
deferred shares financial
"415 of these shares are deferred shares deposited in the director's deferred account"
Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.
director's deferred account financial
"deferred shares deposited in the director's deferred account, which will be automatically distributed"
irrevocable trust financial
"Barbara B Singer 2014 Irrevocable Trust"
dividend reinvestment financial
"Beneficial holdings include 168 shares acquired pursuant to dividend reinvestment through March 2026."
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
beneficial holdings financial
"Beneficial holdings include 168 shares acquired pursuant to dividend reinvestment"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SINGER DAVID V

(Last)(First)(Middle)
C/O BRUNSWICK CORPORATION
26125 N. RIVERWOODS BLVD. SUITE 500

(Street)
METTAWA ILLINOIS 60045

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/30/2026A989(1)A$79.4536,360(2)D
Common Stock19,789IBarbara B Singer 2014 Irrevocable Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. 415 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
2. Beneficial holdings include 168 shares acquired pursuant to dividend reinvestment through March 2026.
Remarks:
By: Power of Attorney For: /s/ David V. Singer05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did BRUNSWICK CORP (BC) director David V. Singer report?

Director David V. Singer reported a grant of 989 shares of Brunswick common stock. The filing classifies this as a grant or award acquisition rather than an open-market purchase, reflecting routine equity compensation rather than a discretionary trading decision.

At what price were the 989 BRUNSWICK CORP (BC) shares granted to David V. Singer?

The 989 shares of Brunswick common stock granted to David V. Singer were valued at $79.45 per share. This price represents the per-share value used for the compensation grant disclosed in the filing, not an open-market trade price chosen by the director.

How many BRUNSWICK CORP (BC) shares does David V. Singer hold after this Form 4 filing?

After the reported grant, David V. Singer directly holds 36,360 Brunswick common shares. He also has indirect beneficial ownership of 19,789 shares through the Barbara B Singer 2014 Irrevocable Trust, according to the ownership details disclosed in the filing.

What is the role of the Barbara B Singer 2014 Irrevocable Trust in BRUNSWICK CORP (BC) holdings?

The Barbara B Singer 2014 Irrevocable Trust holds 19,789 Brunswick common shares reported as indirectly owned by David V. Singer. This means the trust, rather than Singer personally, is the direct holder, and these shares are disclosed as indirect beneficial ownership.

What are the deferred shares mentioned in David V. Singer’s BRUNSWICK CORP (BC) filing?

The filing explains that 415 of the reported Brunswick shares are deferred shares in Singer’s director deferred account. These deferred shares will be automatically distributed in predetermined installments after he ceases serving as a director of the company.

How were dividend reinvestment shares treated in this BRUNSWICK CORP (BC) Form 4?

Footnotes state that beneficial holdings include 168 Brunswick shares acquired via dividend reinvestment through March 2026. These reinvested dividends increase Singer’s reported beneficial ownership without reflecting a separate open-market purchase transaction by the director.